There may be question marks over leadership and collaboration in the German camp ahead of Sunday's World Championships men's road race, but Marcel Kittel and Andre Greipel came together to deliver a scathing assessment of Bradley Wiggins' use of triamcinolone acetonide under Therapeutic Use Exemptions (TUEs).
Speaking at Germany's pre-race press conference on Thursday evening, both sprinters discussed the vexed issue of leadership before suggesting that Wiggins, who says he needed the powerful corticosteroid to treat asthma and allergy issues, should not have been racing if he was so ill.
Kittel went as far as suggesting that someone with Wiggins' ailments should be competing in para-sport.
ADVERTISEMENT
"If someone has severe asthma, then he has no place in performance sport," German media reported Kittel as saying.
"We introduced the Paralympics because we want to give people with one leg a chance to compete against others," he added.
It was revealed last month that Wiggins received injections of triamcinolone on three occasions, ahead of the 2011 Tour de France, the 2012 Tour de France – which he won – and the 2013 Giro d'Italia. No anti-doping rules were broken because the UCI approved the TUE but the issue has sparked controversy on ethical grounds, with a widespread belief that the TUE system creates a grey area whereby athletes can avail of performance enhancing drugs on dubious medical grounds.
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2eh0P4r
No comments:
Post a Comment